These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1066 related items for PubMed ID: 14719996

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacotherapy of the ion transport defect in cystic fibrosis.
    Kunzelmann K, Mall M.
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):857-67. PubMed ID: 11703384
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
    Mroz MS, Harvey BJ.
    Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis.
    Roomans GM.
    Am J Respir Med; 2003 Nov; 2(5):413-31. PubMed ID: 14719993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B, Boeynaems JM.
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.
    Gianotti A, Melani R, Caci E, Sondo E, Ravazzolo R, Galietta LJ, Zegarra-Moran O.
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):445-52. PubMed ID: 23600628
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mathematical model reveals role of nucleotide signaling in airway surface liquid homeostasis and its dysregulation in cystic fibrosis.
    Sandefur CI, Boucher RC, Elston TC.
    Proc Natl Acad Sci U S A; 2017 Aug 29; 114(35):E7272-E7281. PubMed ID: 28808008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis.
    Shei RJ, Peabody JE, Kaza N, Rowe SM.
    Curr Opin Pharmacol; 2018 Dec 29; 43():152-165. PubMed ID: 30340955
    [Abstract] [Full Text] [Related]

  • 20. [CFTR and transepithelial ionic transport abnormalities in cystic fibrosis].
    Becq F.
    Arch Pediatr; 2003 Sep 29; 10 Suppl 2():325s-332s. PubMed ID: 14671929
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.